Back

Eledon Pharmaceuticals to Join Guggenheim Biotech Summit 2026

lite News Desk 2 min read

At a glance

  • Eledon Pharmaceuticals announced participation in a 2026 biotech summit
  • Steven Perrin, Ph.D., will represent the company at the event
  • A webcast replay will be available on Eledon’s website after the session

Eledon Pharmaceuticals, a clinical-stage biotechnology company based in Irvine, California, announced its involvement in an upcoming industry event. The company stated that its President and Chief Scientific Officer, Steven Perrin, Ph.D., will take part in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026.

The scheduled session is set for Thursday, February 12, 2026, at 10:00 a.m. Eastern Time, which corresponds to 7:00 a.m. Pacific Time. The announcement regarding the company’s participation was made from Irvine, California.

Eledon Pharmaceuticals develops immune-modulating therapies and lists tegoprubart, an anti-CD40L antibody, as its lead investigational product. The company’s involvement in the summit aligns with its ongoing activities in the biotechnology sector.

Following the live event, Eledon Pharmaceuticals plans to provide a webcast replay of the fireside chat. According to the company, the recording will be accessible on its website under the Events section.

What the numbers show

  • The fireside chat is scheduled for February 12, 2026
  • The session will begin at 10:00 a.m. ET (7:00 a.m. PT
  • Eledon Pharmaceuticals is headquartered in Irvine, California

Steven Perrin, Ph.D., holds the roles of President and Chief Scientific Officer at Eledon Pharmaceuticals. His participation in the summit is part of the company’s stated efforts to engage with the broader biotechnology community.

The Guggenheim Emerging Outlook: Biotech Summit 2026 is one of several industry events where companies present updates and discuss sector developments. Eledon Pharmaceuticals has indicated that interested parties will be able to view the session after the event through its online platform.

Eledon Pharmaceuticals’ announcement did not specify additional details about the topics to be addressed during the fireside chat. The company’s public communications focus on its ongoing research and development activities.

The webcast replay is intended to provide access to those unable to attend the live session. Eledon Pharmaceuticals has stated that the recording will be posted in the Events section of its website following the conclusion of the chat.

* This article is based on publicly available information at the time of writing.

Related Articles

  1. Biotech firms focus on biologics, while pharmaceutical companies develop chemical drugs. Each sector presents unique risks and investment profiles.

  2. Exercise, especially light to moderate, shows benefits for depression. Walking 7,000 steps daily linked to a 31% lower risk, according to reports.

  3. Researchers investigate CAR T-cell therapy's ability to reverse aging effects in mouse intestines, improving health...

  4. Josh D’Amaro will become CEO of The Walt Disney Company on March 18, 2026. Dana Walden has been appointed President and Chief Creative Officer.

  5. Research shows immunotherapy given before 3 PM improves survival rates and slows cancer progression, according to multiple studies.

More on Health

  1. Vertex Pharmaceuticals reported Q4 2024 revenue of $2.91 billion, a 16% increase year-over-year, according to company statements. Stock closed at $477.92.

  2. A meta-analysis reviewed data from over 120,000 participants, finding no significant excess risk for 62 of 66 side effects, according to researchers.

  3. A measles case was confirmed in Shasta County on January 30. Health officials identified six locations as potential exposure sites.